Literature DB >> 12527902

Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.

Mariko Fukuma1, Hajime Okita, Jun-Ichi Hata, Akihiro Umezawa.   

Abstract

The chromosomal translocation specifically linked to the Ewing sarcoma family results in the generation of fusion proteins comprising the amino terminal portion of EWS and the DNA-binding domain of ets transcription factors. The EWS/ets chimeric proteins act as aberrant transcription factors leading to tumorigenic processes. We searched for genes specifically activated in Ewing sarcoma cells but not in other tumor cell lines using the gene array technique, and found significantly enhanced expression of the Id2 gene. High levels of Id2 transcripts were detected in Ewing sarcoma cell lines and tumor tissues. The EWS/ets chimeric proteins activated the Id2 gene via the 5'-upstream promoter sequence. Chromatin-immunoprecipitation revealed a direct interaction of EWS/Fli-1 with the promoter regions of the Id2, TGF-beta type II receptor, cyclin D1, and c-myc genes. Since EWS/Fli-1 transactivates c-myc, a cooperative action of the chimeric protein and c-myc leads to overexpression of Id2. In the present study, we suggest that Id2 is a target of the chimeric proteins and that the c-myc/Id2 pathway plays a pivotal role in the tumorigenic processes provoked by EWS/ets proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527902     DOI: 10.1038/sj.onc.1206055

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system.

Authors:  Anna Lasorella; Antonio Iavarone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

2.  Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.

Authors:  Yoshitaka Miyagawa; Hajime Okita; Hideki Nakaijima; Yasuomi Horiuchi; Ban Sato; Tomoko Taguchi; Masashi Toyoda; Yohko U Katagiri; Junichiro Fujimoto; Jun-Ichi Hata; Akihiro Umezawa; Nobutaka Kiyokawa
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

3.  Neural differentiation arrest in embryonal carcinoma cells with forced expression of EWS-FLI1.

Authors:  Yu Yang; Lanjing Zhang; Yanyu Wei; Hua Wang; Mariko Fukuma; Hao Xu; Wei Xiong; Jie Zheng
Journal:  J Neurooncol       Date:  2008-07-12       Impact factor: 4.130

Review 4.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

5.  EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.

Authors:  Enrique C Torchia; Kelli Boyd; Jerold E Rehg; Chunxu Qu; Suzanne J Baker
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

6.  GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.

Authors:  Elspeth Beauchamp; Gulay Bulut; Ogan Abaan; Kevin Chen; Akil Merchant; William Matsui; Yoshimi Endo; Jeffrey S Rubin; Jeffrey Toretsky; Aykut Uren
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

7.  Downstream EWS/FLI1 - upstream Ewing's sarcoma.

Authors:  Heinrich Kovar
Journal:  Genome Med       Date:  2010-01-28       Impact factor: 11.117

8.  De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis.

Authors:  Valentina Boeva; Didier Surdez; Noëlle Guillon; Franck Tirode; Anthony P Fejes; Olivier Delattre; Emmanuel Barillot
Journal:  Nucleic Acids Res       Date:  2010-04-07       Impact factor: 16.971

9.  Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma.

Authors:  Patrick P Lin; Yongxing Wang; Guillermina Lozano
Journal:  Sarcoma       Date:  2010-10-05

10.  FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.

Authors:  Weidong Han; Zhiqiang Wu; Yali Zhao; Yuanguang Meng; Yiling Si; Jie Yang; Xiaobing Fu; Li Yu
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.